Management of non-malignant breast lesions in ultrasound-guided core needle biopsy

Yi Li,Yanli Lyu,Yue Zhao,Hongfeng Qin,Lingli Xu

DOI: https://doi.org/10.3877/cma.j.issn.1674-0807.2015.03.007

2015-01-01

Abstract:Objective To explore the management of non-malignant breast lesions in ultrasound-guided core needle biopsy ( CNB ) . Methods The clinical and follow-up data of 1105 patients with non-malignant breast lesions diagnosed by CNB in Shunyi Health Care Hospital for Women and Children, Beijing, China, from 2009 to 2013 were retrospectively reviewed. Pearsonχ2 test or Fisher exact test was used for comparison of rates between groups. Results All 1 105 cases were diagnosed with non-malignant lesion by CNB. Among them, 477 cases underwent surgery ( including 9 cases diagnosed with breast cancer in postoperative pathological diagnosis) , the remaining 628 cases were followed up by mammography or breast ultrasound for 9-65 months and no breast cancer was observed. Among the patients who underwent surgery, 7 cases (11. 9%) in high-risk lesion group and 2 cases ( 0. 5%) in benign lesion group were diagnosed with breast cancer in postoperative pathological diagnosis respectively;the risk of breast cancer in high-risk lesion group was 28. 0-fold as high as that in benign lesion group (OR=28. 0, 95%CI:5. 7-134. 0, P=0. 000). Among 418 patients with benign lesions who underwent surgical excision, 2 cases were diagnosed with breast cancer postoperatively in the 56 patients with discordance between clinical examination and CNB (3. 6%, 2/56), no breast cancer was found in 362 patients with concordant diagnosis (0/362), and the difference was statistically significant (P=0. 018). Conclusion In the patients with non-malignant lesions in CNB diagnosis, except a few patients in high risk or with discordant diagnosis between clinical examination and CNB who requiring surgical resection, periodic clinical breast examination and breast imaging follow-up may be a relatively safe management for most patients.